These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35474364)

  • 21. Measuring utilities of severe facial disfigurement and composite tissue allotransplantation of the face in patients with severe face and neck burns from the perspectives of the general public, medical experts and patients.
    Chuback J; Yarascavitch B; Yarascavitch A; Kaur MN; Martin S; Thoma A
    Burns; 2015 Nov; 41(7):1524-31. PubMed ID: 26068209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimating Utility Values for Health States of DFU Patients Using EQ-5D-5L and cTTO.
    Arab-Zozani M; Safari H; Dori Z; Afshari S; Ameri H; Namiranian N; Hoseini E; Jafari A
    Int J Low Extrem Wounds; 2022 Mar; 21(1):41-49. PubMed ID: 33939495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Value Set Based on DCE and/or TTO Data: Scoring for EQ-5D-5L Health States in Japan.
    Shiroiwa T; Ikeda S; Noto S; Igarashi A; Fukuda T; Saito S; Shimozuma K
    Value Health; 2016; 19(5):648-54. PubMed ID: 27565282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of online and face-to-face valuation of the EQ-5D-5L using composite time trade-off.
    Jiang R; Shaw J; Mühlbacher A; Lee TA; Walton S; Kohlmann T; Norman R; Pickard AS
    Qual Life Res; 2021 May; 30(5):1433-1444. PubMed ID: 33247810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health state utility values for metastatic pancreatic cancer using a composite time trade-off based on the vignette-based approach in Japan.
    Takumoto Y; Sasahara Y; Narimatsu H; Murata T; Akazawa M
    Health Econ Rev; 2022 Dec; 12(1):63. PubMed ID: 36564539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. QALYs without bias? Nonparametric correction of time trade-off and standard gamble weights based on prospect theory.
    Lipman SA; Brouwer WBF; Attema AE
    Health Econ; 2019 Jul; 28(7):843-854. PubMed ID: 31237093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient-assigned health utility values for controlled and uncontrolled pemphigus vulgaris and foliaceus.
    Hajdu K; Brodszky V; Stalmeier PFM; Ruzsa G; Tamási B; Gulácsi L; Péntek M; Sárdy M; Bata-Csörgő Z; Kinyó Á; Szegedi A; Rencz F
    J Eur Acad Dermatol Venereol; 2019 Nov; 33(11):2106-2113. PubMed ID: 31265151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The lead time tradeoff: the case of health states better than dead.
    Pinto-Prades JL; Rodríguez-Míguez E
    Med Decis Making; 2015 Apr; 35(3):305-15. PubMed ID: 25009190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health state utilities for migraine based on attack frequency: a time trade-off study.
    Rencz F; Brodszky V; Péntek M; Bereczki D; Gulácsi L
    Neurol Sci; 2015 Feb; 36(2):197-202. PubMed ID: 25108469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Health utility measurement by time trade-off method in Hungary].
    Balázs PG; Brodszky V; Rencz F
    Orv Hetil; 2021 Mar; 162(14):542-554. PubMed ID: 33784247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time preferences for health in northern Tanzania: an empirical analysis of alternative discounting models.
    Robberstad B; Cairns J
    Pharmacoeconomics; 2007; 25(1):73-88. PubMed ID: 17192119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time preference bias in time trade-off.
    van der Pol M; Roux L
    Eur J Health Econ; 2005 Jun; 6(2):107-11. PubMed ID: 19787847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health State Utilities for Patient's Current Health from Bipolar Type I Disorder.
    Banihashemian M; Rashidian A; Gholamian F; Parsaeian M; Moradi N; Amini H
    J Ment Health Policy Econ; 2018 Mar; 21(1):3-10. PubMed ID: 29643263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advocating a Paradigm Shift in Health-State Valuations: The Estimation of Time-Preference Corrected QALY Tariffs.
    Jonker MF; Donkers B; de Bekker-Grob EW; Stolk EA
    Value Health; 2018 Aug; 21(8):993-1001. PubMed ID: 30098678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utility values in the visually impaired: comparing time-trade off and VisQoL.
    Gothwal VK; Bagga DK
    Optom Vis Sci; 2013 Aug; 90(8):843-54. PubMed ID: 23628757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Utility of 5 Hypothetical Health States in Heart Failure Using Time Trade-Off (TTO) and EQ-5D-5L in Korea.
    Hong SH; Lee JY; Park SK; Nam JH; Song HJ; Park SY; Lee EK
    Clin Drug Investig; 2018 Aug; 38(8):727-736. PubMed ID: 29804184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The EQ-5D-5L valuation study in Korea.
    Kim SH; Ahn J; Ock M; Shin S; Park J; Luo N; Jo MW
    Qual Life Res; 2016 Jul; 25(7):1845-52. PubMed ID: 26961008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using the Analytic Hierarchy Process to Derive Health State Utilities from Ordinal Preference Data.
    Reddy BP; Adams R; Walsh C; Barry M; Kind P
    Value Health; 2015 Sep; 18(6):841-5. PubMed ID: 26409612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute and chronic impact of cardiovascular events on health state utilities.
    Matza LS; Stewart KD; Gandra SR; Delio PR; Fenster BE; Davies EW; Jordan JB; Lothgren M; Feeny DH
    BMC Health Serv Res; 2015 Apr; 15():173. PubMed ID: 25896804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of caregiver and parenting status on time trade-off and standard gamble utility scores for health state descriptions.
    Matza LS; Boye KS; Feeny DH; Johnston JA; Bowman L; Jordan JB
    Health Qual Life Outcomes; 2014 Apr; 12():48. PubMed ID: 24716709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.